Fragment Screening, Protein Production and Research

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Fragment Screening

Protein Production

Research

Target-directed cancer: protein-ligand interactions

Drug Target Review

NOVEMBER 1, 2023

Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. Acta Cryst. Acta Cryst.

Fragment Screening

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays

Sygnature Discovery acquires Peak Proteins

Sygnature Discovery

APRIL 26, 2022

Sygnature have acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein production and related structure determination projects within Sygnature. The Peak Proteins leadership team will also remain with the business.

Fragment Screening

Fragment Screening Protein Production Protein Expression Production

Drug Discovery Digest

Target-directed cancer: protein-ligand interactions

Sygnature Discovery acquires Peak Proteins

Stay Connected